+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Nutrigenomics - Global Strategic Business Report

  • PDF Icon

    Report

  • 89 Pages
  • December 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5304264
The global market for Nutrigenomics was estimated at US$985.3 Million in 2023 and is projected to reach US$2.8 Billion by 2030, growing at a CAGR of 16.1% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Nutrigenomics Market - Key Trends and Drivers Summarized

How Is Nutrigenomics Reshaping Personalized Nutrition?

Nutrigenomics, the study of how genes interact with nutrients and dietary components, is redefining personalized nutrition by offering insights into how an individual’s genetic makeup influences their dietary needs and responses. This field of study helps identify genetic predispositions to various conditions like obesity, diabetes, and cardiovascular diseases, enabling the development of tailored nutritional plans that enhance health outcomes. Nutrigenomics is particularly beneficial in preventive healthcare, where dietary interventions based on genetic information can help manage or mitigate the risk of chronic diseases. With growing consumer awareness of health and wellness, nutrigenomics is becoming an essential component of personalized nutrition, offering more precise dietary recommendations for better health management.

What Are the Key Segments in the Nutrigenomics Market?

Key products include testing kits, services, and supplements designed for genetic-based nutrition interventions. In terms of application, nutrigenomics is used in dietary assessment, weight management, sports nutrition, and preventive healthcare, with preventive healthcare representing the largest segment due to the growing focus on disease prevention through personalized diets. The major end-users of nutrigenomics include research institutions, healthcare providers, genetic testing companies, and consumers seeking personalized diet plans. The increasing availability of direct-to-consumer (DTC) genetic testing services has expanded the reach of nutrigenomics, making it more accessible to a broader audience.

How Is Nutrigenomics Being Integrated Across Health and Wellness Sectors?

Healthcare providers are adopting nutrigenomics to deliver personalized dietary recommendations to patients, particularly for managing conditions like diabetes, obesity, and hypertension. Genetic testing companies offer nutrigenomic tests that provide consumers with insights into their genetic predispositions related to nutrient metabolism, food sensitivities, and vitamin deficiencies. The sports nutrition industry also utilizes nutrigenomics to optimize athletes’ diets based on genetic information, improving performance and recovery. Additionally, wellness programs and fitness centers are incorporating nutrigenomics as part of holistic health management, offering tailored dietary plans that align with individual genetic profiles. The integration of nutrigenomics into digital health platforms and mobile apps has further enhanced consumer access to personalized nutrition guidance.

What Factors Are Driving the Growth in the Nutrigenomics Market?

The growth in the Nutrigenomics market is driven by several factors, including increasing consumer awareness of the link between genetics, diet, and health outcomes. The rising demand for personalized nutrition solutions, driven by growing health consciousness and interest in preventive healthcare, has fueled the adoption of nutrigenomics. Advances in genetic testing technologies have made nutrigenomic analysis more accurate, affordable, and accessible, further boosting market growth. The increasing use of nutrigenomics in weight management, sports nutrition, and chronic disease prevention has also expanded its application. Additionally, the proliferation of DTC genetic testing services and the integration of genetic insights into digital health platforms have contributed to the broader adoption of nutrigenomics across healthcare and wellness sectors.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Nutrigenomics Reagents & Kits segment, which is expected to reach US$2.0 Billion by 2030 with a CAGR of a 16.9%. The Nutrigenomics Services segment is also set to grow at 14.4% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $271.0 Million in 2023, and China, forecasted to grow at an impressive 15.2% CAGR to reach $421.9 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Nutrigenomics Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Nutrigenomics Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Nutrigenomics Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players in the Global Nutrigenomics Market such as BASF SE, Cell-Logic, Danone S.A, Fagron Genomics S.L.U., Genova Diagnostics and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 33 companies featured in this Global Nutrigenomics market report include:

  • BASF SE
  • Cell-Logic
  • Danone S.A
  • Fagron Genomics S.L.U.
  • Genova Diagnostics
  • GX Sciences, LLC.
  • Koninklijke DSM N.V.
  • Metagenics, Inc.
  • Nutrigenomix
  • NutriProCan
  • Unilever
  • Xcode Life

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Global Economic Update
  • Nutrigenomics - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Demand for Personalized Nutrition and Health Supplements Spurs Growth in Nutrigenomics Market
  • Technological Advancements in Genomic Testing and Bioinformatics Strengthen Business Case for Adoption
  • Growing Focus on Tailored Diet Plans and Wellness Programs Expands Addressable Market
  • Expansion of Nutrigenomics in Clinical Laboratories, Nutrition Clinics, and Wellness Centers Fuels Market Growth
  • Increasing Adoption of Nutrigenomics in Weight Management, Metabolic Disorders, and Diabetes Care Expands Market Opportunities
  • Technological Innovations in DNA-Based Dietary Analysis and Nutrient Mapping Propel Market Expansion
  • Rising Focus on Preventive Healthcare and Reducing Chronic Disease Risks Drives Demand for Nutrigenomics
  • Growing Use of Nutrigenomics in Functional Foods, Sports Nutrition, and Dietary Supplements Expands Market Potential
  • Technological Advancements in AI-Powered Nutritional Recommendations and Microbiome Integration Propel Market Growth
  • Increasing Focus on Integrating Nutrigenomics with Telemedicine and Digital Health Platforms Drives Adoption
  • Rising Demand for Nutrigenomics in Fitness, Anti-Aging, and Mental Health Applications Strengthens Global Market
  • Expansion of Nutrigenomics in Personalized Meal Kits, Health Coaching, and Virtual Nutrition Counseling Expands Market Opportunities
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Nutrigenomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 2: World Historic Review for Nutrigenomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 3: World 16-Year Perspective for Nutrigenomics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 5: World Historic Review for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 6: World 16-Year Perspective for Reagents & Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 8: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 9: World 16-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Obesity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 11: World Historic Review for Obesity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 12: World 16-Year Perspective for Obesity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Cancer Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 14: World Historic Review for Cancer Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 15: World 16-Year Perspective for Cancer Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for Cardiovascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 17: World Historic Review for Cardiovascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 18: World 16-Year Perspective for Cardiovascular Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 19: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 20: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 21: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 22: World Nutrigenomics Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Nutrigenomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Table 23: USA Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 24: USA Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 25: USA 16-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2014, 2024 & 2030
  • Table 26: USA Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 27: USA Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 28: USA 16-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2014, 2024 & 2030
CANADA
  • Table 29: Canada Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 30: Canada Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 31: Canada 16-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2014, 2024 & 2030
  • Table 32: Canada Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 33: Canada Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 34: Canada 16-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2014, 2024 & 2030
JAPAN
  • Nutrigenomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • Table 35: Japan Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 36: Japan Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 37: Japan 16-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2014, 2024 & 2030
  • Table 38: Japan Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 39: Japan Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 40: Japan 16-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2014, 2024 & 2030
CHINA
  • Nutrigenomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • Table 41: China Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 42: China Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 43: China 16-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2014, 2024 & 2030
  • Table 44: China Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 45: China Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 46: China 16-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2014, 2024 & 2030
EUROPE
  • Nutrigenomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Table 47: Europe Recent Past, Current & Future Analysis for Nutrigenomics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 48: Europe Historic Review for Nutrigenomics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 49: Europe 16-Year Perspective for Nutrigenomics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • Table 50: Europe Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 51: Europe Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 52: Europe 16-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2014, 2024 & 2030
  • Table 53: Europe Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 54: Europe Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 55: Europe 16-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2014, 2024 & 2030
FRANCE
  • Nutrigenomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • Table 56: France Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 57: France Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 58: France 16-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2014, 2024 & 2030
  • Table 59: France Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 60: France Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 61: France 16-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2014, 2024 & 2030
GERMANY
  • Nutrigenomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • Table 62: Germany Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 63: Germany Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 64: Germany 16-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2014, 2024 & 2030
  • Table 65: Germany Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 66: Germany Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 67: Germany 16-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2014, 2024 & 2030
ITALY
  • Table 68: Italy Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 69: Italy Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 70: Italy 16-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2014, 2024 & 2030
  • Table 71: Italy Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 72: Italy Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 73: Italy 16-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2014, 2024 & 2030
UNITED KINGDOM
  • Nutrigenomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • Table 74: UK Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 75: UK Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 76: UK 16-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2014, 2024 & 2030
  • Table 77: UK Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 78: UK Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 79: UK 16-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2014, 2024 & 2030
REST OF EUROPE
  • Table 80: Rest of Europe Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 81: Rest of Europe Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 82: Rest of Europe 16-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2014, 2024 & 2030
  • Table 83: Rest of Europe Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 84: Rest of Europe Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 85: Rest of Europe 16-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2014, 2024 & 2030
ASIA-PACIFIC
  • Nutrigenomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • Table 86: Asia-Pacific Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 87: Asia-Pacific Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 88: Asia-Pacific 16-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2014, 2024 & 2030
  • Table 89: Asia-Pacific Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 90: Asia-Pacific Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 91: Asia-Pacific 16-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2014, 2024 & 2030
REST OF WORLD
  • Table 92: Rest of World Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 93: Rest of World Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 94: Rest of World 16-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2014, 2024 & 2030
  • Table 95: Rest of World Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 96: Rest of World Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 97: Rest of World 16-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2014, 2024 & 2030
IV. COMPETITION

Companies Mentioned

Some of the 33 companies featured in this Global Nutrigenomics market report include:
  • BASF SE
  • Cell-Logic
  • Danone S.A
  • Fagron Genomics S.L.U.
  • Genova Diagnostics
  • GX Sciences, LLC.
  • Koninklijke DSM N.V.
  • Metagenics, Inc.
  • Nutrigenomix
  • NutriProCan
  • Unilever
  • Xcode Life

Table Information